Muscular dystrophy is a kind of hereditary muscle degenerative disease, usually with progressive muscle atrophy and muscle weakness, which seriously affects daily life. With an in-depth understanding of the pathological mechanism of muscular dystrophy in modern medicine, new therapeutic targets have been continuously discovered, which provides more possibilities for the development of anti-muscular dystrophy drugs.

Protheragen offers a full range of anti-muscular dystrophy APIs to support development and production for customers worldwide.